About
Female
Principal investment experience with Skyline Ventures and TVM As VP of Corporate Development and Strategy at Genomics Collaborative, Anula was responsible for formation and management of relationships with strategic partners, key customers and suppliers Worked as VP at Roche, where she was responsible for the development program of an Antiretroviral drug MBA, Harvard Business School; MD, PhD, Harvard Medical School; M. Phil University of Cambridge
Experience
Astia Angels
View →Member of the Board of Trustees
76San Francisco, California, United StatesAdvice · Angel Investment
TVM Capital
View →Principal Investment
76Munich, Bayern, GermanyHealth Care · Medical
Skyline Ventures
View →Principal Investment
31Palo Alto, California, United StatesFinance · Financial Services
- Board Member · NUA Surgical2024 – present
- Member of the Board of Directors · Mapmygenome
- Board Member · Solarea Bio
Education
- University of Cambridge · M. Phil, unknown
- Harvard Medical School · PhD, unknown
- Harvard Business School · MBA, Business
- Harvard Medical School · MD, unknown
People at Astia Angels
Data from: crunchbase
